“I’m dizzy”: How to help a patient with dizziness effectively and quickly

One of the most common reasons for seeking medical help from doctors of various specialties is a disturbance of balance function, described by patients as dizziness. Despite the apparent simplicity and unambiguity of the complaint, it turns out that under this term patients mean completely different conditions: instability, unsteadiness when walking, swaying, nausea, pre-fainting condition, “fog in the head”, impaired coordination, etc. Often, the patient not only finds it difficult to independently describe his feelings, but also simultaneously lists several descriptors. It is not always possible to specify the patient’s desires, which complicates the diagnosis of dizziness and the establishment of the etiological factor. In connection with the above, an algorithm is currently used in the diagnosis of dizziness, which includes an assessment of the vestibular syndrome by the nature of the course (acute, episodic, chronic), identification of provoking factors (triggers), concomitant symptoms, supplemented by a physical examination, and, if necessary, paraclinical methods. In the treatment of dizziness, priority is given to its rapid and effective relief. For this purpose, drugs are used – vestibular suppressants. Given the high prevalence of comorbid conditions requiring the simultaneous use of several drugs, combination drugs have an advantage. A combination of cinnarizine and dimenhydrinate has demonstrated high efficiency and safety as a symptomatic therapy for dizziness of various origins. The combination of drug therapy with vestibular rehabilitation methods allows achieving better results and longer remission even in chronic cases of dizziness.

1. Brandt T, Dieterich M, Strupp M. Vertigo and Dizziness – Common Complaints. 2nd ed. London: Springer; 2013. 148 p. https://doi.org/10.1007/b138527.

2. Walther LE. Current diagnostic procedures for diagnosing vertigo and dizziness. GMS Curr Top Otorhinolaryngol Head Neck Surg. 2017;16:Doc02. https://doi.org/10.3205/cto000141.

3. Handschu R, Täuber A, Schuh A. Chronic vertigo. MMW Fortschr Med. 2019;161(11):45–52. https://doi.org/10.1007/s15006-019-0020-z.

4. Walther LE, Blödow A. Current aspects of vertigo and dizziness in advanced age. HNO. 2020;68(3):191–198. https://doi.org/10.1007/s00106-019-00756-5.

5. Brandt T, Strupp M. General vestibular testing. Clin Neurophysiol. 2005;116(2):406–426. https://doi.org/10.1016/j.clinph.2004.08.009.

6. Gorobets EA, Esin RG, Esin OR. Verbal description of dizziness by Russianspeaking informants with high and low levels of alexithymia. Philology and Culture. 2018;(4):28–33. (In Russ.) Available at: https://www.elibrary.ru/yvkkwd.

7. Karatas M. Central vertigo and dizziness: Epidemiology, differential diagnosis, and common causes. Neurologist. 2008;14(6):355–364. https://doi.org/10.1097/NRL.0b013e31817533a3.

8. Яхно НН. Головокружение. Большая российская энциклопедия. 2007. Т. 7. С. 344–345. Режим доступа: https://old.bigenc.ru/medicine/text/2367463.

9. Damulin IV, Tardov MV. Falls in the elderly due to vestibular dysfunction: clinical and pathogenetic aspects. Medical Journal of the Russian Federation. 2020;26(2):98–103. (In Russ.) http://doi.org/10.18821/0869-2106-2020-26-2-98-103.

10. Das S, Annam CS, Bakshi SS, Seepana R. Persistent positional perceptual dizziness in clinical practice: a scoping review. Neurol Sci. 2023;44(1):129–135. https://doi.org/10.1007/s10072-022-06353-9.

11. Neuhauser HK, Radtke A, von Brevern M, Lezius F, Feldmann M, Lempert T. Burden of dizziness and vertigo in the community. Arch Intern Med. 2008;168(19):2118–2124. https://doi.org/10.1001/archinte.168.19.2118.

12. Neuhauser HK, Lempert T. Vertigo: epidemiologic aspects. Semin Neurol. 2009;29(5):473–481. https://doi.org/10.1055/s-0029-1241043.

13. Neuhauser H.K. The epidemiology of dizziness and vertigo. Handb Clin Neurol. 2016;137:67–82. https://doi.org/10.1016/B978-0-444-63437-5.00005-4.

14. Bronstein AM. Vision and vertigo: Some visual aspects of vestibular disorders. J Neurol. 2004;251:381–387. https://doi.org/10.1007/s00415-004-0410-7.

15. Sloan PD. Dizziness in primary care. Results from the national ambulatory medical care survey. J Fam Pract. 1989;29(1):33–38. Available at: https://pubmed.ncbi.nlm.nih.gov/2738548.

16. Casani AP, Gufoni M, Capobianco S. Current Insights into Treating Vertigo in Older Adults. Drugs Aging. 2021;38(8):655–670. https://doi.org/10.1007/s40266-021-00877-z.

17. Luxon LM. Evaluation and management of the dizzy patient. J Neurol Neurosurg Psychiatry. 2004;75(4 Suppl.):iv45-iv52. https://doi.org/10.1136/jnnp.2004.055285.

18. Bird JC, Beynon GJ, Prevost AT, Baguley DM. An analysis of referral pattern for dizziness in the primary care setting. Br J Gen Pract. 1998;48(437): 1828–1832. Available at: https://pubmed.ncbi.nlm.nih.gov/10198501.

19. Kosivtsova OV, Starchina YuA, Urtenov KA, Belkina VV. Dizziness in elderly patients: discussion based on a clinical observation. Neurology, Neuropsychiatry, Psychosomatics. 2024;16(4):85–89. (In Russ.) https://doi.org/10.14412/2074-2711-2024-4-85-89.

20. Honrubia V, Bell TS, Harris MR, Baloh RW, Fisher LM. Quantitative evaluation of dizziness characteristics and impact on quality of life. Am J Otol. 1996;17(4):595–602. Available at: https://pubmed.ncbi.nlm.nih.gov/8841705.

21. Parry SW, Steen N, Galloway S, Kenny RA, Bond J. Falls and confidence related quality of life outcome measures in an older British cohort. Postgrad Med J. 2001;77(904):103–108. https://doi.org/10.1136/pmj.77.904.103.

22. Tinetti ME. Preventing falls in elderly persons. N Eng J Med. 2003;348(1):42–49. https://doi.org/10.1056/NEJMcp020719.

23. Brandt T. Vertigo. Its Multisensory Syndromes. London: Springer; 1999. 504 p. Available at: https://springer.com/gp/book/9783540199342.

24. Zamergrad MV, Parfenov VA, Ostroumova OD, Guseva AL, Zaytseva OV, Sivolap YuP et al. Functional dizziness: from diagnostic criteria to clinical profiles and therapy. Expert consensus. Neurology, Neuropsychiatry, Psychosomatics. 2024;16(4):4–13. (In Russ.) https://doi.org/10.14412/2074-2711-2024-4-4-13.

25. Antonenko LM. Current aspects of the treatment of different types of vertigo. Meditsinskiy Sovet. 2021;(19):91–98. (In Russ.) https://doi.org/10.21518/2079-701X-2021-19-91-98.

26. Pizova NV. Potential use of dimensionhydrinate/cinnarizine combination in the treatment of vertigo. Meditsinskiy Sovet. 2021;(21-1):35–44. (In Russ.) https://doi.org/10.21518/2079-701X-2021-21-1-35-44.

27. Guseva AL. Vertigo Attacks: Differential Diagnosis and Approaches to Therapy. Effective Pharmacotherapy. 2021;17(34):16–21. (In Russ.) https://doi.org/10.33978/2307-3586-2021-17-34-16-21.

28. Amelinа IP, Solovieva EY. Vertigo: New Possibilities of Therapy. Effective Pharmacotherapy. 2021;17(38):20–25. (In Russ.) https://doi.org/10.33978/2307-3586-2021-17-38-20-25.

29. Zastenskaia EN, Antonenko LM. Chronic dizziness: modern treatment methods taking into account comorbidity. Neurology, Neuropsychiatry, Psychosomatics. 2023;15(6):71–77. (In Russ.) https://doi.org/10.14412/2074-2711-2023-6-71-77.

30. Machner B, Choi JH, Neumann A, Trillenberg P, Helmchen C. What guides decision-making on intravenous thrombolysis in acute vestibular syndrome and suspected ischemic stroke in the posterior circulation? J Neurol. 2021;268(1):249–264. https://doi.org/10.1007/s00415-020-10134-9.

31. Esin RG, Khaibullina DKh, Esin OR. Dizziness: efficient approach to treatment and prevention. Meditsinskiy Sovet. 2023;17(3):78–83. (In Russ.) https://doi.org/10.21518/ms2023-082.

32. Esin RG, Khaĭrullin IKh, Mukhametova ER, Esin OR. Persistent posturalperceptual dizziness. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2017;117(4):28–33. (In Russ.) https://doi.org/10.17116/jnevro20171174128-33.

33. Newman-Toker DE, Hsieh YH, Camargo CA Jr, Pelletier AJ, Butchy GT, Edlow JA. Spectrum of dizziness visits to US emergency departments: cross-sectional analysis from a nationally representative sample. Mayo Clin Proc. 2008;83(7):765–775. https://doi.org/10.4065/83.7.765.

34. Agus S, Benecke H, Thum C, Strupp M. Clinical and demographic features of vertigo: findings from the REVERT registry. Front Neurol. 2013;4:48. https://doi.org/10.3389/fneur.2013.00048.

35. Bisdorff AR, Staab JP, Newman-Toker DE. Overview of the International Classification of Vestibular Disorders. Neurol Clin. 2015;33(3):541–550. https://doi.org/10.1016/j.ncl.2015.04.010.

36. Kirtane MV, Bhandari A, Narang P, Santani R. Cinnarizine: A Contemporary Review. Indian J Otolaryngol Head Neck Surg. 2019;71(2 Suppl.):1060–1068. https://doi.org/10.1007/s12070-017-1120-7.

37. Viola P, Gioacchini FM, Astorina A, Pisani D, Scarpa A, Marcianò G et al. The pharmacological treatment of acute vestibular syndrome. Front Neurol. 2022;13:999112. https://doi.org/10.3389/fneur.2022.999112.

38. Ivanova GE, Kunelskaya NL, Parfenov VA, Zamergrad MV, Melnikov OA, Guseva AL et al. Vestibular rehabilitation in complex therapy of vestibular vertigo (consensus of experts). Neurology, Neuropsychiatry, Psychosomatics. 2024;16(1): 114–121. (In Russ.) https://doi.org/10.14412/2074-2711-2024-1-114-121.

39. Scholtz AW, Ilgner J, Loader B, Pritschow BW, Weisshaar G. Cinnarizine and dimenhydrinate in the treatment of vertigo in medical practice. Wien Klin Wochenschr. 2016;128(9-10):341–347. https://doi.org/10.1007/s00508-015-0905-5.

40. Hahn A, Novotný M, Shotekov PM, Cirek Z, Bognar-Steinberg I, Baumann W. Comparison of cinnarizine/dimenhydrinate fixed combination with the respective monotherapies for vertigo of various origins: a randomized, double-blind, active-controlled, multicentre study. Clin Drug Investig. 2011;31:371–383. https://doi.org/10.2165/11588920-000000000-00000.

41. Hahn A, Sejna I, Stefflova B, Schwarz M, Baumann W. A fixed combination of cinnarizine/dimenhydrinate for the treatment of patients with acute vertigo due to vestibular disorders: a randomized, reference-controlled clinical study. Clin Drug Investig. 2008;28:89–99. https://doi.org/10.2165/00044011-200828020-00003.

42. Pytel J, Nagy G, Toth A, Spellenberg S, Schwarz M, Repassy G. Efficacy and tolerability of a fixed low-dose combination of cinnarizine and dimenhydrinate in the treatment of vertigo: a 4-week, randomized, double-blind, active- and placebo-controlled, parallel-group, outpatient study. Clin Ther. 2007;29(1):84–98. https://doi.org/10.1016/.clinthera.2007.01.010.

43. Scholtz A-W, Steindl R, Burchardi N, Bognar-Steinberg I, Baumann W. Comparison of the therapeutic efficacy of a fixed low-dose combination of cinnarizine and dimenhydrinate with betahistine in vestibular neuritis: a randomized, double-blind, non-inferiority study. Clin Drug Investig. 2012;32(6):387–399. https://doi.org/10.2165/11632410-000000000-00000.

44. Novotný M, Kostrica R. Fixed combination of cinnarizine and dimenhydrinate versus betahistine dimesylate in the treatment of Meniere’s disease: a randomized, double-blind, parallel group clinical study. Int Tinnitus J. 2002;8(2):115–123. Available at: https://pubmed.ncbi.nlm.nih.gov/14763223.

45. Cirek Z, Schwarz M, Baumann W, Novotny M. Efficacy and tolerability of a fixed combination of cinnarizine and dimenhydrinate versus betahistine in the treatment of otogenic vertigo: a double-blind, randomized clinical study. Clin Drug Investig. 2005;25(6):377–389. https://doi.org/10.2165/00044011-200525060-00003.

46. Otto V, Fischer B, Schwarz M, Baumann W, Preibisch-Effenberger R. Treatment of vertebrobasilar insufficiency-associated vertigo with a fixed combination of cinnarizine and dimenhydrinate. Int Tinnitus J. 2008;14(1):57–67. Available at: https://pubmed.ncbi.nlm.nih.gov/18616088.

47. Schremmer D, Bognar Steinberg I, Baumann W, Pytel J. Efficacy and Tolerability of a Fixed Combination of Cinnarizine and Dimenhydrinate in Treatment of Vertigo. Clinical Drug Investigation. 1999;18(5):355–368. https://doi.org/10.2165/00044011-199918050-00003.

48. Hamann KF. Special ginkgo extract in cases of vertigo: a systematic review of randomised, doubleblind, placebo controlled clinical examinations. HNO. 2007;55(4):258–263. https://doi.org/10.1007/s00106-006-1440-5.

49. Bognar-Steinberg I, Baumann W, Skurczynski W, Kessler L. Treatment of vestibular vertigo: comparison of a fixed combination of cinnarizine 20 mg and dimenhydrinate 40 mg with the 2.5-fold higher dosed active drugs in monotherapy. Arch Sensol Neurootol Sci Pract. 2012;7:1–13. Available at: https://neurootology.org/archives/662.

50. Scholtz AW, Schwarz M, Baumann W, Kleinfeldt D, Scholtz HJ. Treatment of vertigo due to acute unilateral vestibular loss with a fixed combination of cinnarizine and dimenhydrinate: a double-blind, randomized, parallelgroup clinical study. Clin Ther. 2004;26(6):866–877. https://doi.org/10.2165/00044011-200525060-00003.

51. Kim OV, Majidova YoN, Nosirova DSh. Optimizing treatment of patients with vertigo. Vestnik KazNMU. 2015;(2):404–405. (In Russ.) Available at: https://kaznmu.kz/press/wp-content/uploads/2015/07/Вестник-КазНМУ-№2-2015.pdf.

52. Xaydarova GS, Toshpulatov YuA, Xodjayeva ZH. Evaluation of vegetative disorders in patients with headbeat. Avicenna. 2018;(20):19–22. (In Russ.) Available at: https://avicenna-idp.ru/wp-content/uploads/v20.pdf.

53. Scholtz AW, Hahn A, Stefflova B, Medzhidieva D, Ryazantsev SV, Paschinin A, Kunelskaya N et al. Efficacy and Safety of a Fixed Combination of Cinnarizine 20 mg and Dimenhydrinate 40 mg vs Betahistine Dihydrochloride 16 mg in Patients with Peripheral Vestibular Vertigo: A Prospective, Multinational, Multicenter, Double-Blind, Randomized, Non-inferiority Clinical Trial. Clin Drug Investig. 2019;39(11):1045–1056. https://doi.org/10.1007/s40261-019-00858-6.